Enzymatica signs loan agreement with major shareholders
16 June 2022 Regulatory press release Enzymatica signs loan agreement with major shareholders Enzymatica AB has signed a two-year loan agreement of a maximum of 20 MSEK with its three largest shareholders as well as the Chairman of the Board Bengt Baron and the CEO Claus Egstrand. The purpose is to support the company’s liquidity in the periods where sales are lower due to seasonal variations or remaining effects of the pandemic. The company’s three largest shareholders – Mats Andersson, Håkan Roos and Björn Algkvist – have today, 16 June 2022, signed a two-year